Centre Hospitalier Départemental

La Roche-sur-Yon 85025

0 studies enrolling now · 3 studies all time

What they study most

Hormone Refractory Prostate Cancer, Locally Advanced Pancreatic Cancer, Metastatic Pancreas Cancer, Pancreatic Adenocarcinoma, Pancreatic Cancer, Prostate Cancer

Studies at this site

• EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX — Completed
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed
• Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine — Stopped early